Off-label use limitation of the Super Arrow-Flex® sheath introducer in congenital heart disease interventions

2021 ◽  
pp. 1-2
Author(s):  
Raymond N. Haddad ◽  
Enrico Piccinelli ◽  
Zakhia Saliba ◽  
Alain Fraisse
Keyword(s):  
United States ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
United States Of America ◽  
Congenital Heart ◽  
Interventional Procedures ◽  
Off Label Use ◽  
Off Label ◽  
Sheath Introducer ◽  
Label Use

Abstract Many interventionists are infatuated by the recent resurgence of the coilwire design with the Super Arrow-Flex® sheath (Teleflex, Inc., NC, United States of America). This exclusive sheath is a highly flexible, durable, conduit intended for use in diagnostic and interventional procedures with several advantages and maximum effectiveness in challenging cases. We report failure to easily advance memory shape occluders through Super Arrow-Flex® sheaths larger than the recommended implant French size. We detail the technical reasons behind this non-previously reported drawback and describe benchside tests as possible solutions.

Attitude Toward and Current Practice of Transfer and Transition of Adolescents with Congenital Heart Disease in the United States of America and Europe

2009 ◽  
Vol 30 (6) ◽  
pp. 786-793 ◽  
Author(s):  
Deborah Hilderson ◽  
Arwa S. Saidi ◽  
Kristien Van Deyk ◽  
Amy Verstappen ◽  
Adrienne H. Kovacs ◽  
...  
Keyword(s):  
United States ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
United States Of America ◽  
Congenital Heart ◽  
Current Practice ◽  
The United States

Off -label use of Amplatzer devices in congenital heart disorders during childhood

2013 ◽  
Vol 68 (1) ◽  
pp. 31-35 ◽  
Author(s):  
Osman Baspinar ◽  
Ahmet Irdem ◽  
Metin Kilinc
Keyword(s):  
Congenital Heart ◽  
Off Label Use ◽  
Off Label ◽  
Heart Disorders ◽  
Label Use

scholarly journals Increasing off-label use of antipsychotic medications in the United States, 1995-2008

2011 ◽  
Vol 20 (2) ◽  
pp. 177-184 ◽  
Author(s):  
G. C. Alexander ◽  
S. A. Gallagher ◽  
A. Mascola ◽  
R. M. Moloney ◽  
R. S. Stafford
Keyword(s):  
United States ◽  
The United States ◽  
Off Label Use ◽  
Antipsychotic Medications ◽  
Off Label ◽  
Label Use

scholarly journals Discontinuity of Cardiac Follow‐Up in Young People With Congenital Heart Disease Transitioning to Adulthood: A Systematic Review and Meta‐Analysis

2021 ◽  
Author(s):  
Philip Moons ◽  
Sandra Skogby ◽  
Ewa‐Lena Bratt ◽  
Liesl Zühlke ◽  
Ariane Marelli ◽  
...  
Keyword(s):  
United States ◽  
Systematic Review ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Heart Defects ◽  
Meta Analysis ◽  
Transition Programs ◽  
The United States

Background The majority of people born with congenital heart disease require lifelong cardiac follow‐up. However, discontinuity of care is a recognized problem and appears to increase around the transition to adulthood. We performed a systematic review and meta‐analysis to estimate the proportion of adolescents and emerging adults with congenital heart disease discontinuing cardiac follow‐up. In pooled data, we investigated regional differences, disparities by disease complexity, and the impact of transition programs on the discontinuity of care. Methods and Results Searches were performed in PubMed, Embase, Cinahl, and Web of Science. We identified 17 studies, which enrolled 6847 patients. A random effects meta‐analysis of single proportions was performed according to the DerSimonian‐Laird method. Moderator effects were computed to explore sources for heterogeneity. Discontinuity proportions ranged from 3.6% to 62.7%, with a pooled estimated proportion of 26.1% (95% CI, 19.2%–34.6%). A trend toward more discontinuity was observed in simple heart defects (33.7%; 95% CI, 15.6%–58.3%), compared with moderate (25.7%; 95% CI, 15.2%–40.1%) or complex congenital heart disease (22.3%; 95% CI, 16.5%–29.4%) ( P =0.2372). Studies from the United States (34.0%; 95% CI, 24.3%–45.4%), Canada (25.7%; 95% CI, 17.0%–36.7%), and Europe (6.5%; 95% CI, 5.3%–7.9%) differed significantly ( P =0.0004). Transition programs were shown to have the potential to reduce discontinuity of care (12.7%; 95% CI, 2.8%–42.3%) compared with usual care (36.2%; 95% CI, 22.8%–52.2%) ( P =0.1119). Conclusions This meta‐analysis showed that there is a high proportion of discontinuity of care in young people with congenital heart disease. The highest discontinuity proportions were observed in studies from the United States and in patients with simple heart defects. It is suggested that transition programs have a protective effect. Registration URL: www.crd.york.ac.uk/prospero . Unique identifier: CRD42020182413.

Adult Congenital Heart Disease

2014 ◽  
pp. 870-880
Author(s):  
Yuli Y. Kim ◽  
Michael J. Landzberg ◽  
Anne Marie Valente
Keyword(s):  
United States ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
Natural History ◽  
Congenital Heart ◽  
Adult Congenital Heart Disease ◽  
The United States ◽  
Complex Congenital Heart Disease ◽  
Clinical Presentations ◽  
Adult Congenital

Historically, individuals with complex congenital heart disease rarely lived past childhood. Due to tremendous advances in diagnosis and treatment, now 85–90% of children born with congenital heart disease will survive into adulthood. Estimates suggest that over 1 million adults with congenital heart disease currently live in the United States. The number of adults with congenital heart disease (ACHD) is growing by approximately 5% each year. The majority of these patients do not appear to be followed by ACHD specialists. Therefore, it is essential that all physicians familiarize themselves with the unique clinical presentations of these patients, including the anatomy, physiology, and natural history in order to facilitate proper management and referral.

Sign in / Sign up

Export Citation Format

Share Document